Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-10 Sale | 2024-09-12 6:10 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 10,000 | $11 | $110,000 | 146,940 (Direct) | View |
| 2024-05-31 Purchase | 2024-06-04 6:05 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 4,791 | $4.44 | $21,272 | 91,940 (Direct) | View |
| 2023-11-30 Purchase | 2023-12-04 6:03 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 743 | $3.78 | $2,809 | 18,399 (Direct) | View |
| 2023-05-31 Purchase | 2023-06-02 5:03 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 9,997 | $1.41 | $14,096 | 17,656 (Direct) | View |
| 2022-11-30 Purchase | 2023-02-03 6:01 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 3 | $1.41 | $4 | 367,659 (Direct) | View |
| 2022-05-31 Purchase | 2022-06-08 9:27 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 7,656 | $1.47 | $11,254 | 7,656 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-10 Exercise | 2024-09-12 6:10 pm | N/A 2032-01-25 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 10,000 | $0 | 146,940 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-12 6:10 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 10,000 | $5.36 | 146,940 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 7:17 pm | N/A 2034-01-22 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 206,250 | $0 | 224,649 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:01 pm | N/A 2033-01-31 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 360,000 | $0 | 367,659 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 9:02 pm | N/A 2032-01-26 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 9:17 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 120,000 | $0 | 120,000 (Direct) | View |
Ownership | 2021-02-04 5:14 pm | N/A 2030-09-09 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 0 | $0 | 227,807 (Direct) | View |